Navigation Links
Screen all at risk for HIV, plus pregnant women

The new surgical assistant at the University of North Carolina Hospitals arrived in February sporting three arms, a computerized brain and a glowing track record in helping to repair heart valves, remove cancerous prostates, bypass blocked coronary arteries and perform gastric bypass operations for morbid obesity.

The new arrival is a robotic machine, the da Vinci Surgical System, manufactured by Intuitive Surgical. UNC currently is the only gynecological oncology program in the Southeast that is using it.

The robot has been used successfully at UNC for prostate removal surgery; for hysterectomies for endometrial and cervical cancers; and for pediatric gallbladder removal and stomach surgery to prevent gastric reflux.

The robotic system gained federal government approval for gynecological use in April.

"We've found the robotic operation to be more precise than conventional surgery, and it allows a patient to return to normal activities much more quickly, with a shorter hospital stay. We also found a reduced use of pain medications after robotic surgery, with fewer complications," said Dr. John F. Boggess, gynecological oncologist, assistant professor of obstetrics and gynecology at UNC's School of Medicine and a member of the UNC Lineberger Comprehensive Cancer Center.

Boggess is the first physician statewide to be certified to perform gynecological procedures with the robotic system.

In robotic-assisted surgery, the da Vinci robot is an extension of the surgeon's hands in a way not previously possible with minimally invasive surgery via laparoscopy, he said.

"And that's the key to its success," Boggess added. "The robot takes us a big step beyond traditional laparoscopy. It allows us to operate more naturally, the way we do in open surgeries, but still preserve a minimally invasive approach with small incisions."

As in laparoscopy, robotic surgery involves small incisions of one-fourth to three-fourths of an inch, into which sleeves are inserted as ports for placement of specialized instruments and a video camera.

"Robotic surgery allows us to virtually place our hands inside the patient without the need for large incisions," Boggess said.

After sleeve placement, the robot, much like a post with three arms, is wheeled over and its center arm docked to a port that holds the camera and the other arms docked to the instrument ports.

However, surgery with the da Vinci does not mean close proximity to the patient. Unlike with laparoscopy, the surgeon is seated across the room from the patient, with arms inserted into the nearby console, fingers on stirrup-like holders and eyes fixed on lenses for sharp magnified images of the surgical site. Focus is adjusted via foot pedals.

While laparoscopy allows manipulation of instruments up, down and side-to-side, surgery with the da Vinci allows more natural wrist movement.

The robot's arms have wrists with eight degrees of freedom that allow the surgeon "to bend around corners and work in ways that are much more natural," said Boggess. This allows full range of motion and the ability to rotate instruments 360 degrees through tiny incisions. Direct and natural hand-eye instrument alignment is similar to open surgery, with "all-around" vision and the ability to zoom in and out.

Another advantage with da Vinci is the elimination of tremor. Surgeons can scale, or ratio, their finger movement to that of the robotic instrument. A movement of inches at the console can be scaled down to centimeters in the patient.

"This can re-introduce precision in an elderly surgeon, who has all those years of experience but has lost some dexterity," Boggess said.

Dr. Daniel von Allmen, chief of surgery at the N.C. Children's Hospital and associate professor of surgery at UNC, has performed several successful pediatric operations with the da Vinci robotic system and said the scalability was a major advantage.

"This is very important in pediatric surgery, given the smaller space to operate, and for performing refined interventions very precisely," he said, adding that "the ultimate potential for the system, if the instruments can be made small enough, would be its use in fetal surgery, in utero."

Since the arrival of the da Vinci robot at UNC Hospitals in early 2005, several successful "robotic-assisted laparoscopic radical prostatectomies," or RALRPs, have been completed.

The robot is a better tool and an improved instrument compared to what has been used previously, said Dr. Eric M. Wallen, assistant professor of urologic surgery, director of urologic laparoscopy at UNC Hospitals and a UNC Lineberger member.

"I expect that over the next decade, RALRP will become the most common surgery performed for patients with prostate cancer. The robot improves the view that the surgeon has, and its instruments have more flexibility to perform the delicate nerve sparing and sewing parts of the procedure," he said.

Patients, in turn, recover quickly and are able to resume their normal life within days of major surgery instead of months, Boggess said.

"The robot provides the laparoscopic surgeon with a degree of precision and safety not achievable with traditional surgery or laparoscopy and will redefine abdominal/pelvic surgery for the next generation of surgeons," he added.


Source:American College of Physicians

Related biology news :

1. Screening blood for West Nile virus
2. 100 percent of pregnant women have at least one kind of pesticide in their placenta
3. Agreement will speed research on microbicides for women
4. MUHC investigators search for the root of sexual pain in women
5. No link found between caffeine intake and development of hypertension in women
6. Hepatitis B accounts for 40 percent of missing Asian women
7. Anti-HIV drug has potential to prevent transmission in women
8. Tamoxifen for breast cancer prevention does not benefit most women
9. New egg freezing technique offers hope to hundreds of women
10. Ultra low-dose estrogen shown safe for post-menopausal women
11. New brain-chemistry differences found in depressed women
Post Your Comments:

(Date:11/16/2015)... 16, 2015  Synaptics Inc. (NASDAQ: SYNA ... today announced expansion of its TDDI product portfolio ... controller and display driver integration (TDDI) solutions designed ... new TDDI products add to the previously-announced ... (WQHD resolution), and TD4322 (FHD resolution) solutions. All ...
(Date:11/10/2015)... LONDON , Nov. 10, 2015 /PRNewswire/ ... segmented on the basis of product, type, ... segments included in this report are consumables, ... this report are safety biomarkers, efficacy biomarkers, ... in this report are diagnostics development, drug ...
(Date:11/2/2015)... Nov. 2, 2015  SRI International has been awarded ... preclinical development services to the National Cancer Institute (NCI) ... provide scientific expertise, modern testing and support facilities, and ... pharmacology and toxicology studies to evaluate potential cancer prevention ... The PREVENT Cancer Drug Development Program is an NCI-supported ...
Breaking Biology News(10 mins):
(Date:11/25/2015)... DIEGO , Nov. 25, 2015 Orexigen® ... management will participate in a fireside chat discussion at ... New York . The discussion is scheduled ... .  A replay will be ... Media Contact:McDavid Stilwell  , Julie NormartVP, Corporate Communications ...
(Date:11/24/2015)... SUNNYVALE, Calif. , Nov. 24, 2015 ... executives will be speaking at the following conference, and ... New York, NY      Tuesday, December 1, ... New York, NY      Tuesday, December 1, ...      Piper Jaffray Healthcare Conference, New York, NY ...
(Date:11/24/2015)... 2015 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ:  AEZS) (TSX: AEZ) ... of the Toronto Stock Exchange, confirms that as of ... corporate developments that would cause the recent movements in ... --> About Aeterna Zentaris Inc. ... Aeterna Zentaris is a specialty biopharmaceutical company engaged ...
(Date:11/24/2015)... Massachusetts , November 24, 2015 SHPG ... will participate in the Piper Jaffray 27 th Annual Healthcare ... Tuesday, December 1, 2015, at 8:30 a.m. EST (1:30 p.m. GMT). ... , Chief Financial Officer, will participate in the Piper Jaffray 27 ... , NY on Tuesday, December 1, 2015, at 8:30 a.m. ...
Breaking Biology Technology: